In the context of neoplasm, although TGFβ signaling can be both oncogenic and tumor suppressive, a variety of tumors benefit from activated TGFβ signaling, and targeting TGFβ signaling can be a promising therapeutic strategy for cancer treatment.316, 317. The gene discussed is TGFB1; the disease is cancer.